EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Type 2‐high airway inflammation in childhood asthma distinguishes a more severe phenotype

Frederikke R Skov iD, Tamo Sultan, Kasper Fischer-Rasmussen, Bo L Chawes iD, Jakob Stokholm iD, Nilo Vahman, Klaus Bønnelykke, Ann-Marie M Schoos iD

Pediatric Allergy and Immunology · 2025-02 · 36 (2)

DOI: 10.1111/pai.70032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Allergy and Immunology, online erschienen am 04.02.2025. Verfasst von Frederikke R Skov und 7 weiteren Autor:innen. Beteiligte Einrichtung: COPSAC, Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Asthma. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The Lundbeck Foundation, The Ministry of Health, Danish Council for Strategic Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

It remains unclear whether phenotyping of type 2‐high (T2‐high) asthma can distinguish clinical characteristics and lung function trajectories in childhood.

Objective

To explore differences between T2‐high and T2‐low asthma from birth to age 18 years.

Methods

We included 47 children with asthma and 165 as a control group from the Copenhagen Prospective Studies on Asthma in Childhood 2000 mother–child cohort. T2‐high and T2‐low asthma was defined at age 7 by sensitization to aeroallergens, elevated eosinophilic blood count, and/or elevated fractional nitric oxide. Lung function measurements included whole‐body plethysmography, spirometry, exercise test, cold air provocation, and methacholine challenge. Differences in lung function trajectories and traits were analyzed using linear mixed models, Wilcoxon rank‐sum test, Fisher's exact test, and Quasi‐Poisson regression.

Results

At age 7 years, 47 had asthma (26 T2‐high, 21 T2‐low). By age 18, 12 (46.2%) with T2‐high had persistent asthma whereas 2 (9.2%) with T2‐low; OR 8.14 [1.57–42.34]. Specific airway resistance (sRaw) was 12.5% higher through childhood in children with T2‐high asthma (estimate 0.53 [0.06; 1.01]); lung function was more reversible (OR 3.37 [1.03–11.00] for spirometry and OR 2.60 [1.17; 5.75] for sRaw), and they had increased airway hyperresponsiveness (AHR) to methacholine (as shown by 41% lower dose required to cause a 20% drop in lung function (estimate −0.70 [−1.18; −0.23])). There was no significant difference in exacerbation rate and other lung function measurements.

Conclusion

Childhood T2‐high asthma differs from T2‐low asthma in terms of onset, duration, airway resistance, and airway responsiveness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaHumansChildFemaleMalePhenotypeAdolescentChild, PreschoolProspective StudiesInfantRespiratory Function TestsInfant, NewbornSpirometrySeverity of Illness IndexInflammation

Stichwörter der Autor:innen

asthmaeosinophilslongitudinal studiespediatricsphenotype

Autor:innen und Institutionen

  • COPSAC, Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.
  • Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Department of Pediatrics, Slagelse Hospital, Slagelse, Denmark.
  • Section of Microbiology and Fermentation, Department of Food Science, University of Copenhagen, Copenhagen, Denmark.

ORCID-Profile: Frederikke R Skov, Bo L Chawes, Jakob Stokholm, Ann-Marie M Schoos

Förderung

  • The Lundbeck Foundation
  • The Ministry of Health
  • Danish Council for Strategic Research
  • The Capital Region Research Foundation
  • BørnelungefondenNæstved, Slagelse
  • Ringsted Research Foundation Sanofi A/S
  • Ministry of Health
  • Strategiske Forskningsråd

Zitieren

APA

Skov, F. R., Sultan, T., Fischer-Rasmussen, K., Chawes, B. L., Stokholm, J., Vahman, N., Bønnelykke, K., & Schoos, A. M. (2025). Type 2‐high airway inflammation in childhood asthma distinguishes a more severe phenotype. Pediatric Allergy and Immunology, 36(2). https://doi.org/10.1111/pai.70032

Vancouver

Skov FR, Sultan T, Fischer-Rasmussen K, Chawes BL, Stokholm J, Vahman N, et al. Type 2‐high airway inflammation in childhood asthma distinguishes a more severe phenotype. Pediatric Allergy and Immunology. 2025;36(2). doi:10.1111/pai.70032

BibTeX
@article{Skov2025,
  author = {Skov, Frederikke R and Sultan, Tamo and Fischer-Rasmussen, Kasper and Chawes, Bo L and Stokholm, Jakob and Vahman, Nilo and Bønnelykke, Klaus and Schoos, Ann-Marie M},
  title = {Type 2‐high airway inflammation in childhood asthma distinguishes a more severe phenotype},
  journal = {Pediatric Allergy and Immunology},
  year = {2025},
  volume = {36},
  number = {2},
  doi = {10.1111/pai.70032}
}
Kostenlos starten →